Two or three issues side by side. Only issues that are open, upcoming or awaiting listing appear — those are the ones a comparison can act on, and the ones whose figures are actually published.
3 is the most that fits side by side. Remove one to add another.
| Comparing | AP Annu ProjectsMainboard · Upcoming | HI Horizon Industrial Parks LimitedMainboard · Open | SP Symbiotec Pharmalab LimitedMainboard · Upcoming |
|---|---|---|---|
| Issue | |||
| Board | Mainboard | Mainboard | Mainboard |
| Status | Upcoming | Open | Upcoming |
| Price band | — | ₹57 – ₹60 | ₹938 – ₹988 |
| Lot size | — | 250 shares | |
A row is shown only where at least one of these issues has published the figure; a dash means that company has not. Nothing here is a recommendation — CAPITA1 is not registered with SEBI as an investment adviser or a research analyst.
| 15 shares |
| Minimum investmentOne lot at the upper band | — | ₹15,000 | ₹14,820 |
|---|
| Issue size | — | ₹2,600 Cr | ₹1,757 Cr |
|---|
| Face value | — | ₹10 | ₹2 |
|---|
| Registrar | — | KFin Technologies Limited | MUFG Intime India Private Limited |
|---|
| Timeline | |||
|---|---|---|---|
| Open date | 25 Aug 2026 | 17 Aug 2026 | 24 Aug 2026 |
| Close date | 28 Aug 2026 | 19 Aug 2026 | 27 Aug 2026 |
| Allotment date | 31 Aug 2026 | 20 Aug 2026 | 28 Aug 2026 |
| Listing date | 2 Sep 2026 | 24 Aug 2026 | 1 Sep 2026 |
| Valuation | |||
|---|---|---|---|
| P/E ratioAt the upper band. Null where earnings are negative. | — | — | 51.73x |
| EPS | ₹6.91 | ₹-0.95 | ₹19.1 |
| NAV per share | ₹32.48 | ₹23.29 | ₹184.69 |
| Return on equity | 21.27% | — | 11.19% |
| Return on net worth | 21.27% | -4.09% | 9.48% |
| Return on capital employed | 22.66% | — | 11.56% |
| EBITDA margin | 20.81% | 79.07% | 26.59% |
| Market | |||
|---|---|---|---|
| Grey market premiumUnofficial estimate — not an exchange price | — | ₹1.9 (+3.17%) | — |
| Subscribed (overall) | — | 1.45x | 0.00x |
| Subscribed (retail) | — | 0.96x | — |